Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Spero Therapeutics Inc (SPRO)  
$1.75 0.02 (1.16%) as of 4:30 Wed 3/27


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 27,200,000
Market Cap: 47.60(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1 - $1.95
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Spero Therapeutics is a biopharmaceutical company focused on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases where there is high unmet medical and patient need. Co.'s product candidate, tebipenem pivoxil hydrobromide, is designed to be the oral carbapenem-class antibiotic for use to treat certain bacterial infections that cause complicated urinary tract infections, including pyelonephritis, caused by certain microorganisms, in adult patients who have limited oral treatment options. Co.'s pipeline also includes SPR720, an oral treatment for non-tuberculous mycobacterial infection.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 89,727
Total Buy Value $0 $0 $0 $647,391
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 2
Total Shares Sold 229,741 229,741 288,002 2,224,393
Total Sell Value $318,043 $318,043 $392,013 $4,729,239
Total People Sold 5 5 5 6
Total Sell Transactions 6 6 12 18
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 45
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Aquilo Capital, L.p. 10% Owner   –       –       •   2021-09-14 4 B $18.49 $39,872 I/I 2,156 4,429,145 1.5 -37%     
   Aquilo Capital, L.p. 10% Owner   –       –       •   2021-09-13 4 B $18.56 $820,675 I/I 44,210 4,426,989 1.5 -37%     
   Aquilo Capital, L.p. 10% Owner   –       –       •   2021-09-09 4 B $18.50 $457,792 I/I 24,749 4,382,779 1.5 -35%     
   Aquilo Capital, L.p. 10% Owner   –       –       •   2021-08-31 4 B $18.93 $920,660 I/I 48,645 4,358,030 1.5 -34%     
   Aquilo Capital, L.p. 10% Owner   –       –       •   2021-08-30 4 B $17.87 $786,859 I/I 44,042 4,309,385 1.5 -27%     
   Shukla Sath Chief Financial Officer   •       –      –    2021-08-26 4 A $0.00 $0 D/D 24,067 24,067     -
   Larkin Cristina Chief Operating Officer   •       –      –    2021-08-26 4 A $0.00 $0 D/D 24,067 25,567     -
   Mahadevia Ankit CEO and President   •       •      –    2021-08-26 4 A $0.00 $0 D/D 78,219 144,036     -
   Joseph Tamara L Chief Legal Officer   •       –      –    2021-08-26 4 A $0.00 $0 D/D 24,067 24,067     -
   Keutzer Timothy Chief Development Officer   •       –      –    2021-08-26 4 A $0.00 $0 D/D 24,067 26,567     -
   Melnick David A. Chief Medical Officer   •       –      –    2021-08-26 4 A $0.00 $0 D/D 24,067 24,067     -
   Aquilo Capital, L.p. 10% Owner   –       –       •   2021-08-24 4 B $16.28 $653,795 I/I 40,170 4,228,404 1.5 -8%     
   Aquilo Capital, L.p. 10% Owner   –       –       •   2021-08-23 4 B $16.33 $2,251,342 I/I 137,835 4,188,234 1.5 -8%     
   Aquilo Capital, L.p. 10% Owner   –       –       •   2021-08-20 4 B $14.86 $3,286,906 I/I 221,190 4,050,399 1.5 4%     
   Aquilo Capital, L.p. 10% Owner   –       –       •   2021-02-08 4 S $21.74 $65,215 I/I (3,000) 3,829,209 32%     
   Aquilo Capital, L.p. 10% Owner   –       –       •   2021-02-04 4 S $18.99 $648,255 I/I (34,144) 3,832,209 22%     
   Aquilo Capital, L.p. 10% Owner   –       –       •   2021-02-03 4 S $18.98 $557,101 I/I (29,354) 3,866,353 20%     
   Aquilo Capital, L.p. 10% Owner   –       –       •   2021-02-02 4 S $18.99 $433,771 I/I (22,841) 3,895,707 17%     
   Aquilo Capital, L.p. 10% Owner   –       –       •   2021-02-01 4 S $19.24 $262,861 I/I (13,661) 3,918,548 20%     
   Aquilo Capital, L.p. 10% Owner   –       –       •   2020-12-17 4 S $18.81 $4,703,225 I/I (250,000) 3,932,209 26%     
   Larkin Cristina Chief Operating Officer   •       –      –    2020-12-16 4 AS $19.00 $228,000 D/D (12,000) 1,500 -22%     
   Larkin Cristina Chief Operating Officer   •       –      –    2020-12-16 4 OE $5.90 $70,800 D/D 12,000 13,500     -
   Aquilo Capital, L.p. 10% Owner   –       –       •   2020-12-16 4 S $18.62 $278,035 I/I (14,933) 4,182,209 22%     
   Aquilo Capital, L.p. 10% Owner   –       –       •   2020-11-09 4 S $13.77 $1,734,071 I/I (125,900) 4,197,142 -12%     
   Aquilo Capital, L.p. 10% Owner   –       –       •   2020-11-06 4 S $13.77 $68,874 I/I (5,000) 4,323,042 -16%     

  45 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed